Moreover, evidence on the long-term efficacy and safety of prolonged use, as well as combination therapy with other drugs, remains insufficient
Coverage for tirzepatide varies among insurers, but many now include it for weight management with prior approval
Key points Obesity is a risk factor for developing osteoarthritis (OA), gout, rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA), and is associated with higher disease activity and/or severity, and worse response to common treatments
Unlike compounds that act directly on peripheral vascular pathways, PT-141 has been studied for central nervous systemmediated melanocortin activity
A more useful view comes from repeated testing across many samples and many vendors
Campbell SA, Johnson J, Light PE